Lisinopril
NDC 43063-814, Lisinopril, tablet, from PD-Rx Pharmaceuticals, Inc..
- Product NDC
- 43063-814
- Status
- Listed
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075743
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43063-814 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISINOPRIL30 mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43063-814-01 | 43063081401 | 100 TABLET in 1 BOTTLE, PLASTIC (43063-814-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b62815f3-77fc-4074-a28a-918ab5cc32db
Use it
Look up 43063-814 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43063-814 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43063-814. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.